Bio2Business - Facilitating Biopartnering

SANOFI CALLS ON CMO FOR REPEAT C14 PROJECT

FRENCH pharmaceutical company sanofi-aventis has once again selected contract manufacturing organisation (CMO) SCM Pharma for the fast-tracked fill/finish of a radio-labelled product. Just a year after appointing the UK-based specialist manufacturer... Read News in full

Biotec launches specialist primary packing service

UK-based pharmaceutical services company, Biotec Services International Ltd, has introduced a new MHRA approved primary packing service to meet growing demands from pharmaceutical and biotech companies worldwide. The new primary packing suite will... Read News in full

Melbourn Scientific offers faster formulation for product development

See Melbourn Scientific at ICSE 2010 Hall 4, Stand 4F110 A new fast formulation screening service, that will accelerate the development of formulations where poor bioavailability is an issue, is to be announced by Melbourn Scientific at ICSE. The... Read News in full

SANOFI CALLS ON CMO FOR REPEAT C14 PROJECT

FRENCH pharmaceutical company sanofi-aventis has once again selected contract manufacturing organisation (CMO) SCM Pharma for the fast-tracked fill/finish of a radio-labelled product. Just a year after appointing the UK-based specialist manufacturer... Read News in full

CMO UNVEILS TESTING SERVICES

FILL/FINISH specialist SCM Pharma has launched two new testing services to complement its sterile manufacturing capabilities and reduce the risks associated with offsite testing for client projects.   The UK-based contract manufacturing organisation... Read News in full

Single Crystal X-Ray Determination Partnership

UK pharmaceutical process research and development specialist Park Place Research and Cambridge University X-ray department (Dr John Davies) are pleased to announce a collaboration, for single crystal structural determination. Park Place Research... Read News in full

UK CMO SECURES NEW BUSINESS

FILL/FINISH specialist SCM Pharma has picked up several new and repeat contracts that will initially be worth around £500k, including its first US-based client. The projects, which cover the manufacturing and supply of drug products for clinical trials... Read News in full

Biotec invest in ultra low temperature storage

Leading UK-based pharmaceutical services company, Biotec Services International, has expanded its ultra low temperature storage capacity to accommodate growing demand for the long term storage of biopharmaceuticals. The 300% increase in ultra low storage... Read News in full

NEW RESEARCH COLLABORATION TO ADVANCE STEM CELL USE

A new collaborative research project has secured a government investment of £200,000 to develop technology which could pave the way for dramatic advances in life science research. North East-based Orla Protein Technologies Ltd, The UK Stem Cell Bank... Read News in full

Press Release - Solvias invites you to the 9th Solvias Science Day

With the upcoming event, the science and technology service company will be adding extra strings to its bow far beyond chemical development and catalysis and will for the first time be offering a series of lectures on solid-state development and on the... Read News in full

Veeda Oncology Announces $8.4 million in New Business

Veeda Oncology®, a full service Oncology CRO with facilities in North America, Europe and India, has been awarded over $8.4 million of new clinical research programs over the past 30 days. The awarded work will be conducted in India, Europe and the... Read News in full

Simon Saxby Joins Board at Selcia

Ongar, Essex, United Kingdom (28 June 2010). Selcia Limited, a leading provider of contract research services in 14-C custom radiolabelling, integrated drug discovery, fragment screening and medicinal chemistry today announced the high profile appointment... Read News in full

Solvias AG announces agreement for the manufacturing of the active pharmaceutical ingredient (API) for Rottapharm|Madaus’s phase I candidate, CR4056.

Rottapharm | Madaus is developing CR 4056 for the treatment of neuropathic pain and acute non-specific pain states. CR 4056 is a novel imidazoline (I2) ligand endowed with potent analgesic activities demonstrated in different animal models related to... Read News in full

Invitation to the 9th Solvias Science Day

New Trends, Strategies and Technologies in Research & Development Date: Monday, October 25th, 2010 Place: Congress Center Basel, Switzerland Time: 8:50 a.m. - 5 p.m. Fee: Free of charge Program Description: The program will feature contributions... Read News in full

DUTCH DRUG DEVELOPMENT CLUSTER

CML Europe is a founder member of the Dutch Drug Development Cluster, a group of companies who have come together to align service offerings to the biotech/emerging pharma sector. All globally recognised in their respective fields, AVANTIUM PHARMA, SYNCOM,... Read News in full

Ubichem approved for cGMP radiolabelled API production

Ubichem, a leading provider of chemistry services to the drug development sector, through its Hungarian operation – Ubichem Research - has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled Active Pharmaceutical... Read News in full

'Partner with experience' Melbourn Scientific advises at ERBI

Are Biotech companies missing out on cost-saving wisdom? For biotech companies who want to extend their cash runways in the face of funding shortfalls, working with a well established, highly regulated partner could enable delivery milestones to be... Read News in full

SCM Delivers For University Of Oxford

FILL/FINISH specialist SCM Pharma (www.scm-pharma.com) has successfully completed a fast-tracked aseptic processing project for internationally-famous academic institution, the University of Oxford. The project team at the university’s Clinical Biomanufacturing... Read News in full

Chemoswed extends analytical capabilities and upgrades kilolab facilities

We continue to update and extend our capabilities by adding techniques and instruments which enhance our ability to accomodate customer needs. The growing number of transition metal-assisted transformations applied within API manufacture, and an ever... Read News in full

Asterand Sponsors Inaugural Human Tissue Research Conference

Asterand Sponsors Inaugural Human Tissue Conference Opinion Leaders share insights on human tissue models, cancer research and drug discovery Asterand plc (LSE: ATD), a leading global supplier of human tissue and human tissue-based research services... Read News in full

Asterand and Ono initiate multi-year drug discovery collaboration

ASTERAND’S SUBSIDIARY BIOSEEK AND ONO INITIATE NEW MULTI-YEAR DRUG DISCOVERY COLLABORATION SOUTH SAN FRANCISCO, CA, USA and OSAKA, JAPAN – March 22, 2010 – BioSeek, LLC,a subsidiary of Asterand plc (LSE: ATD), a pioneer in the application of predictive... Read News in full

Asterand accepted into Good Laboratory Practice (GLP) Compliance Program

Asterand’s UK Facility Accepted into Good Laboratory Practice (GLP) Compliance Monitoring Programme The Company Extends its Service Offering into the Preclinical Development Market Asterand plc (LSE: ATD), a leading provider of human tissue and... Read News in full

Lab Research Announces Its 2009 Financial Results

Quarterly backlog improvement of 31.4% 54% jump in request for quotations and new services launched to drive double-digit revenue growth in local currencies in the first quarter of 2010. LAVAL, QC, March 31, 2010 - LAB Research Inc. ("LAB Research"... Read News in full

MELBOURN SCIENTIFIC APPLIES MORPHOLOGI G3 TO PRE-FORMULATION

Melbourn first to offer Malvern’s award wining image processing technology As part of an extension to its product development capabilities, Melbourn Scientific has become the first contract research organisation in Europe to invest in the award winning... Read News in full

Provepharm announces acceptance of Proveblue® injectable drug MAA for review under EMEA centralized procedure and valida

Novasep, a leading supplier of manufacturing solutions to the life sciences industries, and Provepharm, a start-up specialized in the development of pharmaceutical applications for Proveblue®, announce today the successful validation by Novasep of a cGMP... Read News in full

Agenda 1 launch training and recruitment affiliate

Agenda 1 Analytical Services Ltd recently announced the formation and launch of Agenda 1 Scientific Training and Recruitment Ltd (Agenda 1 STaR). This company is lead by Simon Ackroyd, with many years experience in the industry and supported by a team... Read News in full

UK-BASED SCM Pharma has launched a commercial supply service.

UK-BASED SCM Pharma has launched a commercial supply service and has already secured its first long-term ongoing contracts. The contract manufacturing organisation (CMO), which has built a world-class reputation for clinical trial development and... Read News in full

Strengthening of leadership team to prepare Pharma business for spin-out

Avantium appoints Gunnar Staaf as CEO Pharma December 16, 2009, Amsterdam, The Netherlands Today, Avantium announced the appointment of Gunnar Staaf as Chief Executive Officer of its pharmaceutical business. Gunnar Staaf previously worked at Serentis... Read News in full

Crystal Structure Prediction: a new service opening up exciting possibilities for the pharmaceutical industry

Avantium and AMS start collaboration to develop and commercialize Crystal Structure Prediction November 6, 2009 - Amsterdam, The Netherlands and Freiburg, Germany Avantium and Avant-garde Materials Simulations (AMS) announced today that they have... Read News in full

Avantium successfully delivers Solid State Research Workflow to Daiichi Sankyo

15 October 2009 - Amsterdam, The Netherlands Avantium announced today that, in partnership with Mitsubishi Corporation, it has entered into a technology transfer agreement with Daiichi Sankyo Company Limited. Under this agreement Avantium supplies its... Read News in full

Pharmaterials add Xcelodose

As part of our “First in Man Fast” approach, Pharmaterials are delighted to offer cGMP precision powder filling into capsules using Xcelodose® contract manufacturing in our UK facility. This technology can be used to fill small quantities of API alone... Read News in full

CML Expands Capacity in Europe and the US

CML is proud to announce the commissioning of additional capacity on both continents. A new state-of-the-art production facility, containing 6 fully segregated reactor suites with total capacity 70.000L, is now in operation in Wisconsin. This is a world-class... Read News in full

Solvias AG wins European Outsourcing Award 2009

The award was received in the category “Best Analytical Contract Project”. Solvias performed the complete analysis within strict deadlines for the CMC documentation for IDM Pharma’s orphan medicinal product MEPACT®. The combination of professional project... Read News in full

Solvias AG and SARcode Corporation Announce Chemical Development and GMP Manufacturing Agreement

Solvias AG and SARcode Corporation have entered into an expanded agreement for the chemical development and manufacturing of SARcode›s active pharmaceutical ingredient (API) SAR 1118. Solvias will provide ongoing process R&D support and deliver SAR 1118... Read News in full

Novasep gains SafeBridge® "Potent Compound Safety Certification" for its Le Mans facility

Novasep is pleased to announce that its site in Le Mans - France, specialized in the development and manufacturing of Highly Potent Active Pharmaceutical Ingredients (HPAIs), has received the “Potent Compound Safety Certification” from SafeBridge® Consultants,... Read News in full

Sygnature Chemical Services Awarded £390,000 Grant for Business Investment by emda

Nottingham, UK – July 27th, 2009 – Sygnature Chemical Services Ltd., a leading provider of medicinal chemistry and computational chemistry services to the global pharmaceutical industry, has been awarded a £390,000 Grant for Business Investment (GBI)... Read News in full

Sygnature Chemical Services Strengthens Leadership Team; Dr. Paul Clewlow Appointed as Senior Vice-President, Business D

Nottingham, UK 6th April 2009 – Sygnature Chemical Services Ltd., a leading provider of medicinal chemistry, synthetic chemistry and chemical library services, is pleased to announce the appointment of Dr. Paul Clewlow as Senior Vice-President, Business... Read News in full

Sygnature Chemical Services Announces New Appointments to the Board of Directors

Nottingham, UK 6th April 2009 – Sygnature Chemical Services is pleased to announce two new appointments to the Board of Directors: Dr Jonathan G Williams becomes Director of Operations following four years as Principle Research Chemist at Sygnature... Read News in full

Sygnature Chemical Services Extends its Research Facilities Again in BioCity Nottingham

Nottingham, UK 6th April 2009 – Due to an unprecedented demand for its contract medicinal chemistry services, Sygnature Chemical Services has already outgrown the purpose-designed and built laboratory and office space occupied during the £1M expansion... Read News in full

Recent expansion at High Force Research ltd

Investment in analytical capabilities coupled with current and planned additional personnel backed by the award of a Grant for Business Investment (GBI) from One North East, with support from the European Regional Development Fund, has seen High Force... Read News in full

Swissmedic grants Solvias approval to manufacture APIs for clinical trials

Solvias complements its services with a new GMP kilo laboratory. The first custom manufacturing campaign for an active pharmaceutical ingredient (API) will start this month. The newly designed and approved facility complements the existing kilo laboratory... Read News in full

Solvias Completes a Major Manufacturing Campaign for Rolic Technologies Ltd.

Solvias delivered more than 200 kg of a key component, meeting Rolic’s very high quality expectations for application in their photo alignment technology. Commencing with initial process research and development, Solvias moved the campaign swiftly... Read News in full

Novasep acquires bioprocess development specialist and contract manufacturer Henogen

Pompey, France, July 2, 2009 - Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announces today the acquisition of Henogen, a contract manufacturing organization (CMO)... Read News in full

Solvias Announces Construction of cGMP Kilo Lab in Basel (Switzerland)

Solvias has announced the construction of its new kg-scale cGMP manufacturing plant in Basel, which is planned to be operational within Q2/09. The facility will complement the existing state-of-the-art kilo lab by rapid and cost-effective manufacturing... Read News in full